# Safety and Efficacy of Softgel KOVIR (TD0068) in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR)

> **NCT05082727** · PHASE2 · UNKNOWN · sponsor: **Sao Thai Duong Joint Stock Company** · enrollment: 60 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DIETARY_SUPPLEMENT:** KOVIR (TD0068) oral softgel
- **DIETARY_SUPPLEMENT:** Placebo oral softgel

## Key facts

- **NCT ID:** NCT05082727
- **Lead sponsor:** Sao Thai Duong Joint Stock Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2022-09-15
- **Final completion:** 2022-11-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05082727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05082727, "Safety and Efficacy of Softgel KOVIR (TD0068) in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05082727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*